Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:34:38.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T12:59:41.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record. This makes the study details and navigation inaccessible to users.
    Difference
    21%
    Check dated 2026-09-20T04:51:46.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The study record adds a U.S. NIH grant/contract funding line, and the page footer updates to Revision: v3.6.6, indicating a minor version update.
    Difference
    0.1%
    Check dated 2026-08-29T23:43:08.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page’s revision is updated to v3.6.5 from v3.6.4, indicating a minor internal update to the page.
    Difference
    0.0%
    Check dated 2026-08-08T20:00:24.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a new deployment of the site. This update does not reflect a substantive change to the study details or content on the page.
    Difference
    0.0%
    Check dated 2026-07-25T12:32:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.